Aluminum Hydroxide / magnesium carbonate Oral Suspension
- Brand(s)
- Acid Gone, Gaviscon
- Category(s)
- otc
- SPL Type(s)
- Human OTC
- Master SPL
- Glaxosmithkline Consumer Healthcare Lp (2015-11-20)
- Oldest Current Product
- 2000-01-01
- License(s)
- OTC MONOGRAPH FINAL
- RxNORM
- ORAL SUSPENSION\ALUMINUM HYDROXIDE:MAGNESIUM CARBONATE
- SPL Active
- ORAL\LIQUID\ALUMINUM HYDROXIDE: MAGNESIUM CARBONATE
ORAL\SUSPENSION\ALUMINUM HYDROXIDE: MAGNESIUM CARBONATE - SPL Moiety
- ORAL\LIQUID\ALUMINUM HYDROXIDE: CARBONATE ION
ORAL\SUSPENSION\ALUMINUM HYDROXIDE: CARBONATE ION
product(s) by strength(s)
aluminum hydroxide 50.8 mg/ml / magnesium carbonate 47.5 mg/ml oral suspension
product(s)(s)
| # | id | brand | category | labeler | first marketed | active ingredient(s) | route | dose form | spl |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 001350095 | Gaviscon | OTC MONOGRAPH FINAL | Glaxosmithkline Consumer Healthcare Lp | 2011-01-14 | ALUMINUM HYDROXIDE, MAGNESIUM CARBONATE | ORAL | LIQUID | 2d74e5bc-1f10-4fb6-9258-cd906e360013 |
| 2 | 001350574 | Gaviscon | OTC MONOGRAPH FINAL | Glaxosmithkline Consumer Healthcare Lp | 2014-08-01 | ALUMINUM HYDROXIDE, MAGNESIUM CARBONATE | ORAL | LIQUID | 2d74e5bc-1f10-4fb6-9258-cd906e360013 |
aluminum hydroxide 6.33 mg/ml / magnesium carbonate 23.9 mg/ml oral suspension
product(s)(s)
| # | id | brand | category | labeler | first marketed | active ingredient(s) | route | dose form | spl |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 001350094 | Gaviscon | OTC MONOGRAPH FINAL | Glaxosmithkline Consumer Healthcare Lp | 2011-01-14 | ALUMINUM HYDROXIDE, MAGNESIUM CARBONATE | ORAL | LIQUID | 2d74e5bc-1f10-4fb6-9258-cd906e360013 |
| 2 | 009047727 | Acid Gone | OTC MONOGRAPH FINAL | Major | 2004-12-30 | ALUMINUM HYDROXIDE, MAGNESIUM CARBONATE | ORAL | LIQUID | 3d353a92-92f1-4304-8895-31d39dccd88c |
| 3 | 538070137 | OTC MONOGRAPH FINAL | Rij Pharmaceutical Corporation | 2013-04-03 | ALUMINUM HYDROXIDE, MAGNESIUM CARBONATE | ORAL | LIQUID | be7fb10d-dda0-41ae-8122-2ff74180ae92 | |
| 4 | 578960617 | OTC MONOGRAPH FINAL | Gericare Pharmaceuticals | 2000-01-01 | ALUMINUM HYDROXIDE, MAGNESIUM CARBONATE | ORAL | SUSPENSION | cba05ba8-2e3d-4317-bd61-c5d7c626ea0a |
spl(s)
| # | id | title | category | type | labeler | labeler act | last update | version | product(s) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2d74e5bc-1f10-4fb6-9258-cd906e360013 (view SPL) | Drug Facts | otc | Human OTC | Glaxosmithkline Consumer Healthcare Lp | 2015-11-20 | 7 | 001350094, 001350095, 001350574 | |
| 2 | 3d353a92-92f1-4304-8895-31d39dccd88c (view SPL) | Drug Facts | otc | Human OTC | Major | 2012-08-28 | 2 | 009047727 | |
| 3 | be7fb10d-dda0-41ae-8122-2ff74180ae92 (view SPL) | Drug Facts | otc | Human OTC | Rij Pharmaceutical Corporation | 2013-04-03 | 1 | 538070137 | |
| 4 | cba05ba8-2e3d-4317-bd61-c5d7c626ea0a (view SPL) | otc | Human OTC | Gericare Pharmaceuticals | manufacture | 2012-07-16 | 1 | 578960617 |